Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$510M |
| 2 |
Pfizer
PFE
|
+$265M |
| 3 |
Gilead Sciences
GILD
|
+$212M |
| 4 |
Comcast
CMCSA
|
+$191M |
| 5 |
Meta Platforms (Facebook)
META
|
+$184M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$369M |
| 2 |
SIAL
SIGMA - ALDRICH CORP
SIAL
|
+$330M |
| 3 |
MJN
Mead Johnson Nutrition Company
MJN
|
+$230M |
| 4 |
Amgen
AMGN
|
+$223M |
| 5 |
Teva Pharmaceuticals
TEVA
|
+$145M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.47% |
| 2 | Healthcare | 12.72% |
| 3 | Financials | 10.51% |
| 4 | Industrials | 9.69% |
| 5 | Consumer Staples | 9.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ARGO
1601
DELISTED
Argo Group International Holdings, Ltd.
ARGO
| $4.3M | 0.01% |
90,969
+63,645
| +233% | +$3.12M |
|
1602
Korea Electric Power
KEP
$14.8B
| $4.3M | 0.01% |
202,931
+161,100
| +385% | +$3.5M |
|
1603
OSI Systems
OSIS
$3.77B
| $4.29M | 0.01% |
+48,408
| New | +$4.24M |
|
1604
Diodes
DIOD
$4.48B
| $4.29M | 0.01% |
186,727
-45,734
| -20% | -$1.03M |
|
1605
Alto Ingredients
ALTO
$326M
| $4.29M | 0.01% |
+896,382
| New | +$4.69M |
|
1606
Donaldson
DCI
$11.1B
| $4.27M | 0.01% |
149,000
+59,400
| +66% | +$1.75M |
|
1607
Mercury Insurance
MCY
$5.81B
| $4.27M | 0.01% |
91,649
+67,449
| +279% | +$3.42M |
|
|
SSNI
1608
DELISTED
Silver Spring Networks, Inc.
SSNI
| $4.26M | 0.01% |
295,700
+145,600
| +97% | +$2.03M |
|
1609
CAE Inc. Common Shares
CAE
$8.47B
| $4.25M | 0.01% |
383,500
+20,600
| +6% | +$231K |
|
1610
Healthcare Realty
HR
$6.58B
| $4.24M | 0.01% |
157,300
+63,428
| +68% | +$1.64M |
|
|
EARN
1611
Ellington Residential Mortgage REIT
EARN
$167M
| $4.24M | 0.01% |
343,000
+4,800
| +1% | +$61.1K |
|
1612
Service Corp International
SCI
$11.3B
| $4.23M | 0.01% |
+162,600
| New | +$4.44M |
|
1613
BancFirst
BANF
$3.89B
| $4.23M | 0.01% |
144,200
+19,000
| +15% | +$590K |
|
|
CO
1614
DELISTED
Global Cord Blood Corporation
CO
| $4.22M | 0.01% |
662,855
+98,855
| +18% | +$624K |
|
|
DVAX
1615
DELISTED
Dynavax Technologies
DVAX
| $4.21M | 0.01% |
174,473
-128,078
| -42% | -$3.21M |
|
|
BCOV
1616
DELISTED
Brightcove, Inc.
BCOV
| $4.21M | 0.01% |
678,400
+318,100
| +88% | +$1.95M |
|
|
PTR
1617
DELISTED
PETROCHINA COMPANY LIMITED ADS (REP 100 H SHARES)
PTR
| $4.19M | 0.01% |
63,930
-177,470
| -74% | -$13.1M |
|
|
HBI
1618
DELISTED
Hanesbrands
HBI
| $4.18M | 0.01% |
+142,100
| New | +$4.26M |
|
|
NEWP
1619
DELISTED
NEWPORT CORP
NEWP
| $4.17M | 0.01% |
262,800
+651
| +0.2% | +$10.2K |
|
1620
Moelis & Co
MC
$5.21B
| $4.17M | 0.01% |
142,739
+27,539
| +24% | +$788K |
|
|
VXX
1621
DELISTED
iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019
VXX
| $4.16M | 0.01% |
12,944
+11,038
| +579% | +$3.51M |
|
|
BSMX
1622
DELISTED
Banco Santander México, S, A., Institución de Banca Múltiple, Grupo Financiero Santander México
BSMX
| $4.16M | 0.01% |
479,400
+190,000
| +66% | +$1.67M |
|
|
WSTL
1623
DELISTED
Westell Technologies Inc
WSTL
| $4.15M | 0.01% |
824,158
+48,951
| +6% | +$253K |
|
|
DCH
1624
Dauch Corp
DCH
$1.6B
| $4.13M | 0.01% |
+218,200
| New | +$4.59M |
|
1625
BJ's Restaurants
BJRI
$1.42B
| $4.12M | 0.01% |
94,729
+26,200
| +38% | +$1.15M |
|
Similar funds
Jim Simons's Q4 2015 Portfolio in Review
As of Q4 2015, Jim Simons held 3,639 positions worth $45.9B, up 9.5% from $41.9B the previous quarter. Its ten largest holdings account for 9.3% of the portfolio.
Jim Simons deployed $3.07B of net new capital in Q4 2015, opening 509 new positions and adding to 1,872 existing holdings. Its largest new stake was Apple: 17,852,932 shares worth $470M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 11% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Alphabet (Google) Class C, an estimated $369M trimmed.
- Jim Simons's largest Q4 2015 buy was Apple: 17,852,932 shares worth $470M.
- Jim Simons added most to Gilead Sciences in Q4 2015, an estimated $212M increase.
- Jim Simons's biggest Q4 2015 reduction was Alphabet (Google) Class C, cutting an estimated $369M.
- Jim Simons fully exited SIGMA - ALDRICH CORP in Q4 2015, selling an estimated $330M.
- Jim Simons's ten largest holdings make up 9.3% of its $45.9B portfolio in Q4 2015.
- Jim Simons opened 509 new positions and closed 386 in Q4 2015.
- Jim Simons's portfolio value rose 9.5% quarter-over-quarter to $45.9B.
Based on Renaissance Technologies's 13F filing for Q4 2015, filed 11 Feb 2016.